The substance of entrepreneurship and the entrepreneurship of substances

Author:

March Raymond J.,Martin Adam G.,Redford Audrey

Abstract

Purpose – The purpose of this paper is to clarify the distinctions and complementary of William Baumol and Israel Kirzner’s classifications of and insights into entrepreneurship, and thus providing a more complete taxonomy of the substance of entrepreneurial activity. This paper also attempts to clarify distinctions between unproductive and destructive entrepreneurship. Design/methodology/approach – This paper illustrates a more complete taxonomy of the substance of entrepreneurial activity by examining entrepreneurial innovation in drug markets both legal and illegal, identifying cases of productive, unproductive, superfluous, erroneous, destructive, and protective entrepreneurship. Findings – This paper finds that the classifications of entrepreneurship (productive, superfluous, unproductive, erroneous, protective and destructive) put forth by Baumol, Kirzner, and the institutional entrepreneurship literature are complementary. While Baumol seeks to explain the disequilibrating tendencies of entrepreneurship, Kirzner seeks to explain the equilibrating tendencies of entrepreneurship within the institutional context. Originality/value – This paper utilizes case studies from legal and illegal drug markets to uniquely and better explain the six cases of entrepreneurship. This paper also contributes to the literature by clearly articulating the complementarity of Baumolian and Kirznerian entrepreneurship.

Publisher

Emerald

Subject

General Medicine

Reference87 articles.

1. Adriance, S. (2014), “Fighting for the ‘right to try’ unapproved drugs: law and persuasion”, The Yale Law Review Forum , Vol. 124, pp. 148-157.

2. Altman, L.K. (1982), “A new insulin given approval for use in the US”, The New York Times, October 30, available at: www.nytimes.com/1982/10/30/us/a-new-insulin-given-approval-for-use-in-us.html (accessed September 30, 2015).

3. Ballantine, C. (1981), “Sulfanilamide disaster”, FDA Consumer Magazine, June, available at: www.fda.gov/aboutfda/whatwedo/history/productregulation/sulfanilamidedisaster/default.htm (accessed May 15, 2016).

4. Bateman-House, A. , Kimberly, L. , Redman, B. , Dubler, N. and Caplan, A. (2015), “Right-to-try laws: hope, hype, and unintended consequences”, Annals of Internal Medicine , Vol. 163 No. 10, pp. 796-797.

5. Baumol, W.J. (1990), “Entrepreneurship: productive, unproductive, and destructive”, Journal of Political Economy , Vol. 98 No. 5, pp. 893-921.

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3